SHPI has some seasonality so Q4 revenue and earnings are expected to be slightly lower than Q3. Here is a quote from the Q3 press release: "With organic revenue growth of 23% for the quarter and expanded profitability, we believe we are on-track to achieve the mid-to-high end of our financial goals for 2007,” continued Mr. Soinski. “We are also optimistic about our continued growth prospects, as we put new growth initiatives in place for 2008, including the anticipated expansion of our core safety Huber needle business to international markets.” Their guidance was for 30-40% revenue growth which would indicate 2007 revenue of $17,249,727 – $18,576,629. That implies Q4 revenue of $4,254,026 - $4,917,477 which would be down slightly from Q3 revenue of $5,069,283. Having said that, I wouldn't be surprised if they beat the top end of their guidance as they seem to under promise and over deliver.
Mike
